(Reuters) -German medical technology company Siemens Healthineers reported revenue growth and full-year adjusted earnings before interest and taxes (EBIT) in line with estimates on Wednesday, despite facing continued weakness in China.

The comparable revenue growth came in at 4.7% for the year ended Sept. 30, slightly missing analysts' expectations of a 4.8% growth, according to a Vara Research-compiled consensus. It was also at the lower end of the company's forecast of 4.5%-6.5%.

The adjusted EBIT was at 3.5 billion euros ($3.77 billion), meeting analysts' estimates.

The company said it now expects a 5%-6% comparable revenue growth in 2025 and the adjusted basic earnings per share (EPS) to be between 2.35 euros and 2.50 euros.

The annual adjusted EPS touched 2.23 euros this year and was in the expected range of 2.10 euros to 2.30 euros.

($1 = 0.9294 euros)

(Reporting by Marleen Kaesebier; Editing by Sumana Nandy)